Stocks of Note for Jul-10 Morning

These stocks are making interesting moves on high volume.

Active Stocks Moving Up Today

Therapeutics Acquisition Corp. (TXAC) < (TXAC) is currently trading at $14.99 + 1.25 (9.06%). Therapeutics Acquisition Corp. (TXAC) < is -- for the past 30 days, -- year-to-date, and -- over the last 12 months.

(No Data Available)

Greenland Technologies Holding Corporation (GTEC) < (GTEC) is currently trading at $3.32 + 0.56 (20.29%). Greenland Technologies Holding Corporation (GTEC) < is -2.59% for the past 30 days, -33.60% year-to-date, and -70.49% over the last 12 months.

(No Data Available)

Entasis Therapeutics Holdings Inc. (ETTX) < (ETTX) is currently trading at $3.03 + 0.24 (8.60%). Entasis Therapeutics Holdings Inc. (ETTX) < is +2.35% for the past 30 days, -39.03% year-to-date, and -51.82% over the last 12 months.

(No Data Available)

Matson Inc. (MATX) < (MATX) is currently trading at $33.80 + 6.44 (23.54%). Matson Inc. (MATX) < is +4.81% for the past 30 days, -17.16% year-to-date, and -11.51% over the last 12 months.

Matson Inc is a holding company, consisting of two segments, ocean transportation and logistics. The company also provides container stevedoring, container equipment maintenance and other terminal services for MatNav and other ocean carriers.

INmune Bio Inc. (INMB) < (INMB) is currently trading at $7.30 + 1.20 (19.67%). INmune Bio Inc. (INMB) < is +19.05% for the past 30 days, +25.86% year-to-date, and -35.12% over the last 12 months.

(No Data Available)

Greenbrier Companies Inc. (The) (GBX) < (GBX) is currently trading at $24.30 + 2.58 (11.88%). Greenbrier Companies Inc. (The) (GBX) < is +6.82% for the past 30 days, -25.07% year-to-date, and -10.14% over the last 12 months.

Greenbrier Companies Inc designs, manufactures & markets railroad freight car equipment in North America & Europe, marine barges in North America and provides wheel services, railcar refurbishment and parts, leasing & other services to the railroad.

Anixa Biosciences Inc. (ANIX) < (ANIX) is currently trading at $3.30 + 0.379 (12.98%). Anixa Biosciences Inc. (ANIX) < is +53.78% for the past 30 days, +0.58% year-to-date, and -23.83% over the last 12 months.

ITUS Corp is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers.

Sorrento Therapeutics Inc. (SRNE) < (SRNE) is currently trading at $8.36 + 0.61 (7.87%). Sorrento Therapeutics Inc. (SRNE) < is +78.09% for the past 30 days, +147.34% year-to-date, and +224.71% over the last 12 months.

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune\/inflammation diseases.

Wah Fu Education Group Limited (WAFU) < (WAFU) is currently trading at $7.71 + 2.71 (54.20%). Wah Fu Education Group Limited (WAFU) < is +209.56% for the past 30 days, +414.00% year-to-date, and +129.07% over the last 12 months.

(No Data Available)

Spartan Energy Acquisition Corp Class A (SPAQ) < (SPAQ) is currently trading at $17.07 + 2.08 (13.88%). Spartan Energy Acquisition Corp Class A (SPAQ) < is +63.20% for the past 30 days, +67.88% year-to-date, and +68.27% over the last 12 months.

(No Data Available)

Active Stocks Moving Down Today

AeroCentury Corp. (ACY) < (ACY) is currently trading at $2.67 – 0.1695 (5.97%). AeroCentury Corp. (ACY) < is +12.45% for the past 30 days, -40.66% year-to-date, and -66.18% over the last 12 months.

AeroCentury Corp is an aircraft operating lessor and finance company which specializes in leasing regional turboprop and jet aircraft and engines to regional air carriers.

Avita Therapeutics Inc. (RCEL) < (RCEL) is currently trading at $27.26 – 1.795 (6.18%). Avita Therapeutics Inc. (RCEL) < is -17.15% for the past 30 days, -40.10% year-to-date, and -10.64% over the last 12 months.

Avita Medical Ltd is engaged in developing and distributing regenerative products for the treatment of a range of wounds, scars, and skin defects. The company\’s lead product ReCell is used in the treatment of a variety of burns, plastic, and others.

Oncternal Therapeutics Inc. (ONCT) < (ONCT) is currently trading at $2.27 – 0.21 (8.47%). Oncternal Therapeutics Inc. (ONCT) < is -20.63% for the past 30 days, -42.53% year-to-date, and -61.53% over the last 12 months.

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.

Abeona Therapeutics Inc. (ABEO) < (ABEO) is currently trading at $3.11 – 0.24 (7.16%). Abeona Therapeutics Inc. (ABEO) < is +8.56% for the past 30 days, -4.89% year-to-date, and -29.65% over the last 12 months.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.

Corvus Pharmaceuticals Inc. (CRVS) < (CRVS) is currently trading at $4.63 – 0.39 (7.77%). Corvus Pharmaceuticals Inc. (CRVS) < is +39.21% for the past 30 days, -14.89% year-to-date, and -18.71% over the last 12 months.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.

Marinus Pharmaceuticals Inc. (MRNS) < (MRNS) is currently trading at $2.06 – 0.34 (14.17%). Marinus Pharmaceuticals Inc. (MRNS) < is -16.86% for the past 30 days, -4.63% year-to-date, and -53.33% over the last 12 months.

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.

Centogene N.V. (CNTG) < (CNTG) is currently trading at $13.65 – 3.42 (20.04%). Centogene N.V. (CNTG) < is -26.93% for the past 30 days, +35.55% year-to-date, and -- over the last 12 months.

(No Data Available)

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.